Frazier Management

Latest statistics and disclosures from Frazier Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SRRA, ALNA, and represent 100.00% of Frazier Management's stock portfolio.
  • Reduced shares in these 10 stocks: ARQT (-$175M), PHAT (-$115M), IMGO (-$70M), SNDX (-$61M), GRTS (-$60M), MIRM (-$57M), PCVX (-$55M), KRYS (-$54M), PRDS (-$40M), CRNX (-$39M).
  • Sold out of its positions in ACRS, ALPN, ANAB, APTX, ARQT, ARVN, AUTL, AVDL, BCYC, KDNY.
  • Frazier Management was a net seller of stock by $-1.3B.
  • Frazier Management has $2.0M in assets under management (AUM), dropping by -99.85%.
  • Central Index Key (CIK): 0001032165

Tip: Access up to 7 years of quarterly data

Positions held by Frazier Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Frazier Management

Companies in the Frazier Management portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Sierra Oncology Com New (SRRA) 88.1 $1.8M -95% 55k 32.06
Allena Pharmaceuticals (ALNA) 11.9 $236k -38% 1.0M 0.23

Past Filings by Frazier Management

SEC 13F filings are viewable for Frazier Management going back to 2015

View all past filings